ADC Therapeutics cuts deal with Sobi to broaden reach of cancer drug

ADC Therapeutics on Friday announced a deal with Swedish drugmaker Sobi to develop and commercialize its cancer medicine Zynlonta in Europe and other regions outside the U.S.